Access to sophisticated diagnostics and high quality treatment comes as a costly affair for most TB patients. This leads to inconsistencies in proper follow-up of this disease, in turn leading to uneven patient care and under-diagnosis.

Thyrocare has joined the Initiative for Promoting Affordable and Quality TB Tests (IPAQT) as a partner laboratory. This initiative has made all WHO-endorsed Tuberculosis (TB) tests available at affordable prices in the private sector.